IT IS difficult to understand the most recent results from UDG Healthcare plc (originally known as United Drug) where chief executive Brendan McAtamney has been in situ since 2016. Restatement of profits from preceding years has made the figures almost impenetrable but the bottom line is that UDG is not doing nearly as well as… Read more »
To access this content, you must be a Phoenix subscriber.
Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!